Loss of TNFα sensitivity leads to tumor immune evasion independent of perforin-mediated killing, suggesting that resensitizing cancer cells to TNFα-mediated killing might be a potent mechanism for killing antigen-negative tumor cells [26, 27]. The gene discussed is PRF1; the disease is cancer.